Clinical Trials

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT05941520 2026-03-18

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

Phase 2 Recruiting

80 enrolled

Phase 3 Active not recruiting

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT02954874 2026-03-17

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

1,155 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02515110 2026-03-13

Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer

137 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Phase 2/3 Suspended

928 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT06671912 2026-03-04

LoTam

Phase 3 Suspended

1,156 enrolled

Phase 2 Not yet recruiting

Breast Carcinoma In Situ

NCT07443943 2026-03-02

AIMSS-RPS

20 enrolled

Breast Carcinoma In Situ

NCT05898789 2026-02-25

Virtual Rehabilitation for Cancer Survivors

BreastGastrointestinalHead & NeckLymphoid

388 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Lymphoproliferative Disorders, Colorectal Neoplasms

NCT04906200 2026-02-19

YES

400 enrolled

Phase 1 Not yet recruiting

Breast Carcinoma In Situ

NCT07408856 2026-02-13

CAN1012 in OED, DCIS, and LCIS.

60 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT03766009 2026-02-11

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

627 enrolled 9 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT04368702 2026-02-09

CONFIRM

BreastGastrointestinalGenitourinaryHead & NeckLymphoid

70 enrolled

Breast Carcinoma In Situ, Urinary Bladder Neoplasms, Laryngeal Diseases, Laryngeal Neoplasms, Lymphoma, Stomach Neoplasms, Lymphoma, Mantle-Cell

NCT07042581 2026-02-06

A Study of Revaree Plus in People With Breast Cancer

Phase 4 Recruiting

60 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT04054557 2026-02-05

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

Phase NA Completed

305 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT06115486 2026-02-04

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

30 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma in Situ, Hypertrophy, Motor Activity, Neoplasms

NCT04570956 2026-01-23

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Phase 2 Terminated

65 enrolled

Breast Carcinoma In Situ, Breast Neoplasms

NCT04959474 2026-01-23

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

80 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Triple Negative Breast Neoplasms

NCT04871516 2026-01-22

Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer

103 enrolled

Breast Carcinoma In Situ

NCT04754412 2026-01-20

Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study

256 enrolled

Breast Carcinoma In Situ

NCT03345420 2025-12-30

NOVEMBER

Phase 2 Completed

102 enrolled 12 charts